Webinar - Innovations in AML care: Integrating Novel Treatments into Nordic Practice
2026-02-26 14:00 - 15:15 (Europe/Paris) | https://www.namlg.org/event/webinar-innovations-in-aml-care/
The Nordic AML Group’s Educational Working Group invites you to a scientific webinar focusing on recent innovations in the treatment of AML and their implementation in Nordic clinical practice.
The webinar will feature three expert speakers covering:
– The evolving AML treatment landscape by professor Gail Roboz (New York)
– Early Nordic experience with new AML therapies and ongoing Nordic studies by professor Bjørn Tore Gjertsen (Bergen)
– Access pathways and future developments in AML care by associate professor Anne Louise Tølbøll Sørensen (Copenhagen)
Aim: To provide a clinically relevant and up-to-date overview of emerging therapeutic approaches for AML, with particular emphasis on feasibility, relevance, and early adoption within the Nordic region.
Format: Webinar via Zoom via this link
Sponsorship: Sponsored by Otsuka. The sponsor has no influence on the scientific content or agenda.
#################################
Agenda – 2026-02-26 – 14:00 – 15:15 (CET)
14:00 – 14:05 – Welcome & Introduction
14:05 – 14:20 – The Evolving AML Landscape, Professor Gail Roboz (New York)
14:20 – 14:35 – From Data to Practice: Early Nordic Experience with New AML Treatments, Professor Bjørn Tore Gjertsen (Bergen)
14:35 – 14:45 – Discussion
14:45 – 15:00 – Ongoing Nordic Studies, Access Pathways, and What’s Coming Next, Associate professor Anne Louise Tølbøll Sørensen (Copenhagen)
15:00 – 15:10 – Discussion
15:10 – 15:15 – Closing remarks
#################################

NAMLG – Steering group meeting
2026-03-03 16:00 - 17:00
Agenda and meeting link will be sent via e-mail.

Germline Predisposition to Myeloid Neoplasms - Case discussions
2026-03-05 15:00 - 16:00
Join the MDR for patients with germline predisposition for hematological malignancies.
This meeting is for clinicians within the Nordics via this Zoom-link.
If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.

Webinar - Ask the expert: FLT3 MRD testing in AML patients
2026-03-17 17:00 - 18:00
Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda:
Assess the current minimal residual disease testing modalities/methods
 Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities
 Summarize the appropriate treatment strategies in a post-transplant setting
 Best practice sharing in developing/setting up FLT3 MRD testing
More info and register here.

Germline Predisposition to Myeloid Neoplasms – Case discussions
2026-05-07 15:00 - 16:00
Join the MDR for patients with germline predisposition for hematological malignancies.
This meeting is for clinicians within the Nordics.via this Zoom-link.
If you want to discuss a case, please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.

NAMLG meeting @ EHA2026
2026-06-13 00:30 - 14:00

AML Course Day 2026 - Bergen
2026-09-16 08:00 - 17:00

Nordic AML Meeting 2026 - Bergen
2026-09-17 - 2026-09-18
